Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page history and the HHS Vulnerability Disclosure link was removed from the footer, reflecting site-wide release notes rather than changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision history shows addition of v3.3.2 and removal of v3.2.0 on the Study Record Versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removal of a site-wide government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T07:25:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status, Study Design, Outcome Measures, and Adverse Events across multiple versions, with notes on Quality Control status. There are also updates to Contacts/Locations within the record.
    Difference
    0.1%
    Check dated 2025-11-03T21:25:54.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    12%
    Check dated 2025-10-06T06:57:41.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:35:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.